Skip to main content

Closed

MYGN: Myriad Genetics, Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-11.6%

ROIC-18.1%

Financially safe

Stretched

Debt / equity0.69×

Interest coverage-11.4×

Current ratio2.21×

Myriad Genetics, Inc.

MYGNNASDAQ·USD·Closed

Myriad Genetics, Inc.

MYGNNASDAQ·USD·Closed

$2.86

−46.74%

$2.86

−$2.51 (46.74%)

52W Range

1thpctl

Volume

9.21×avg

Mkt Cap

270.12MUSD

P/E

-2.4TTM

Div Yield

–ann

52W Range

1thpctl

Volume

9.21×avg

Market Cap

270.12MUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings